Chronic urticaria: new immunologic aspects.
Riboldi
Piersandro
P
Allergy and Clinical Immunology Unit, IRCCS Istituto Auxologico, Department of Internal Medicine, University of Milan, Italy. piersandro.riboldi@unimi.it
Asero
Riccardo
R
Tedeschi
Alberto
A
Gerosa
Maria
M
Meroni
Pier L
PL
D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000276:immunology; D002908:Chronic Disease; D015936:Complement C5a / Q000276:immunology; D006683:HLA-DQ Antigens / Q000235:genetics / Q000276:immunology; D059866:HLA-DQ beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D059811:HLA-DRB1 Chains; D006636:Histamine Release / Q000235:genetics / Q000276:immunology; D006801:Humans; D008403:Mass Screening / Q000379:methods; D008407:Mast Cells / Q000276:immunology; D010375:Pedigree; D015995:Prevalence; D017455:Receptors, IgE / Q000276:immunology; D014581:Urticaria / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000276:immunology*
D001323:Autoantibodies; D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D017455:Receptors, IgE; D015936:Complement C5a